| 1 |
31540689 | Estradiol regulation of P-glycoprotein expression in mouse kidney and human tubular epithelial cells, implication for renal clearance of drugs. | 2019 Nov 12 |
1 |
| 2 |
28222448 | Acute Effects of Viral Exposure on P-Glycoprotein Function in the Mouse Fetal Blood-Brain Barrier. | 2017 |
1 |
| 3 |
26058994 | Drug-Drug Interactions of a Novel κ-Opioid Receptor Agonist, Nalfurafine Hydrochloride, Involving the P-Glycoprotein. | 2016 Oct |
1 |
| 4 |
27452443 | The effect of 17α-ethynylestradiol induced intrahepatic cholestasis of pregnancy on placental P-glycoprotein in mice: Implications in the individualized transplacental digoxin treatment for fetal heart failure. | 2016 Aug |
2 |
| 5 |
23395915 | Effect of repeated dosing on rifampin exposure in BALB/c mice. | 2013 Apr 11 |
2 |
| 6 |
23468867 | Effects of sertraline and fluoxetine on p-glycoprotein at barrier sites: in vivo and in vitro approaches. | 2013 |
1 |
| 7 |
23762418 | Prenatal endotoxemia and placental drug transport in the mouse: placental size-specific effects. | 2013 |
1 |
| 8 |
23794039 | Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer's disease. | 2013 Nov |
1 |
| 9 |
22266779 | Cerebrospinal fluid can be used as a surrogate to assess brain exposures of breast cancer resistance protein and P-glycoprotein substrates. | 2012 Apr |
3 |
| 10 |
21191377 | Rifampin's acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug-drug interaction trial design. | 2011 Feb |
3 |
| 11 |
21421739 | 1Alpha,25-dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-/-) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice in vivo. | 2011 Jun |
1 |
| 12 |
19833843 | Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier. | 2010 Jan |
1 |
| 13 |
17683917 | A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs. | 2008 Mar |
1 |
| 14 |
18812023 | Lack of difference in pulmonary absorption of digoxin, a P-glycoprotein substrate, in mdr1a-deficient and mdr1a-competent mice. | 2008 Oct |
1 |
| 15 |
16306209 | Ontogeny of renal P-glycoprotein expression in mice: correlation with digoxin renal clearance. | 2005 Dec |
5 |
| 16 |
14569074 | Effect of interferon-gamma on the pharmacokinetics of digoxin, a P-glycoprotein substrate, intravenously injected into the mouse. | 2004 Jan |
1 |
| 17 |
14744937 | Effect of recombinant interleukin-2 pretreatment on oral and intravenous digoxin pharmacokinetics and P-glycoprotein activity in mice. | 2004 Feb |
1 |
| 18 |
12950465 | Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. | 2003 Sep |
2 |
| 19 |
11914641 | Recombinant interleukin-2 treatment decreases P-glycoprotein activity and paclitaxel metabolism in mice. | 2002 Jan |
1 |
| 20 |
11959808 | Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice. | 2002 Apr |
1 |
| 21 |
12128165 | Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice. | 2002 Aug |
4 |
| 22 |
12130739 | Effect of interleukin-2 on intestinal P-glycoprotein expression and functionality in mice. | 2002 Aug |
2 |
| 23 |
10562306 | Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. | 1999 Nov |
1 |
| 24 |
8647944 | P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. | 1996 Jun 1 |
1 |